Clarifying the dynamic change in PD-L1 expression and TILs infiltration before and after NAC in cervical cancer is clinically relevant because it provides a rationale for use of immune checkpoint inhibitors in the adjuvant setting. The gene discussed is CD274; the disease is cervical cancer.